CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

CAT No

CAS No

MW

:

:

:

:MF

Haloperidol Decanoate

For more information on our products custom synthesis, contact SynZeal today.

standards@synzeal.com www.synzeal.com

SZ-H003001

Haloperidol Decanoate

74050-97-8

C31H41ClFNO3

530.11

SZ-H003002

Haloperidol Decanoate EP Impurity A

1797824-64-6

C31H42FNO3

495.68

SZ-H003003

Haloperidol Decanoate EP Impurity B

C31H41ClFNO3

530.12

SZ-H003004

Haloperidol Decanoate EP Impurity C

1797982-02-5

C33H45ClFNO3

558.18

SZ-H003005

Haloperidol Decanoate EP Impurity D

1797008-46-8

C42H54Cl2N2O4

721.8

SZ-H003006

Haloperidol Decanoate EP Impurity E

1796933-22-6

C37H45ClFNO3

606.22

SZ-H003007

Haloperidol Decanoate EP Impurity F

1797131-50-0

C37H45ClFNO3

606.22

SZ-H003008

Haloperidol Decanoate EP Impurity H

1134807-34-3

C29H37ClFNO3

502.07

SZ-H003009

Haloperidol Decanoate EP Impurity I

C30H39ClFNO3

516.09

SZ-H003010

Haloperidol Decanoate EP Impurity J

1797983-18-6

C32H43ClFNO3

544.2

SZ-H003011

Haloperidol Decanoate EP Impurity K

65135-24-2

C33H45ClFNO3

558.2

SZ-H003012

Haloperidol Decanoate EP Impurity L

403-42-9

C8H7FO

138.1

SZ-H003020

Haloperidol Decanoate N-Oxide

C31H41ClFNO4

546.1

SZ-H003021

Bromoperidol decanoate

75067-66-2

C31H41BrFNO3

574.6

N/A

N/A

N/A

SynZeal Research offers all related impurities which certified COA with all characterization data like IR, Haloperidol Decanoate Mass, HPLC purity,NMR & TGA report. We also provide CMR, DEPT and detailed structurecharacterization report as perrequirements.

related products are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.Haloperidol Decanoate

A phenyl-piperidinyl-butyrophenone, traditional antipsychotic drug that is used primarily to treat schizophrenia and other psychoses. It is also used for the management of schizoaffective disorder, delusional disorders, ballism, and Tourette syndrome (a drug of choice) and occasionally as adjunctive therapy in mental retardation and the chorea associated with Huntington's disease. It is a potent antiemetic and is used in the treatment of intractable hiccups.The efficacy of haloperidol was first established in controlled trials in the 1960s.

Interestingly, in vivo pharmacogenetic studies have demonstrated that the metabolism of haloperidol may be modulated by genetically determined polymorphic CYP2D6 activity. However, these findings contradict the findings from studies in vitro with human liver microsomes and from drug interaction studies in vivo. Inter-ethnic and pharmacogenetic differences in haloperidol metabolism may possibly explain these observations.